Biotechnology
Cancer Prevention
Health

Exact Sciences

$96.88
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.88 (3.06%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Exact Sciences and other stocks, options, ETFs, and crypto commission-free!

About

Exact Sciences Corporation Common Stock, also called Exact Sciences, is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. Read More The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Employees
1,977
Headquarters
Madison, Wisconsin
Founded
1995
Market Cap
12.51B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.99M
High Today
$97.43
Low Today
$94.62
Open Price
$94.62
Volume
498.49K
52 Week High
$105.28
52 Week Low
$47.78

Collections

Biotechnology
Cancer Prevention
Health
Technology

News

NasdaqMay 3

EXAS Crosses Above Average Analyst Target

In recent trading, shares of EXACT Sciences Corp. (Symbol: EXAS) have crossed above the average analyst 12-month target price of $101.12, changing hands for $101.65/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher - if things are looking up for the...

361
Markets InsiderMay 2

Exact Sciences' Journey From $11 To $101

(RTTNews) - Shares of Exact Sciences Corporation (EXAS) touched an all-time high of $101 in intraday trading on Wednesday, and that reflects an impressive 63% gain in just four months.

393
The Motley FoolMay 1

Exact Sciences Corp (EXAS) Q1 2019 Earnings Call Transcript

163

Earnings

-$0.65
-$0.49
-$0.34
-$0.18
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 31, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.